Current Pharmacological Trends on Myricetin

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Myricetin is a flavonol found in various natural sources like fruits, vegetables, tea, berries, and red wine.
• Its chemical structure, characterized by a pyrogallol B-ring and extensive hydroxylation, contributes to enhanced biological activities compared to other flavonols.
• Myricetin is produced by several plant families, including Myricaceae, Anacardiaceae, Polygonaceae, Pinaceae, and Primulacea.

Purpose of the Study:

• To review the diverse pharmacological activities of Myricetin.
• To focus on the therapeutic potential of Myricetin in various disease models.
• To consolidate information on Myricetin's effects on osteoporotic, inflammatory, neurodegenerative, epileptic, cancerous, cardiac, metabolic, hepatic, and gastrointestinal disorders.

Main Methods:

• Literature review of scientific articles and research papers.
• Analysis of Myricetin's chemical properties and solubility.
• Compilation of data on Myricetin's reported pharmacological effects and therapeutic applications.

Main Results:

• Myricetin demonstrates a broad spectrum of pharmacological activities, including antioxidant, anti-amyloidogenic, antibacterial, antiviral, antidiabetic, anticancer, anti-inflammatory, anti-epileptic, and anti-ulcer effects.
• The compound is soluble in organic solvents like ethanol, DMSO, and DMF, but sparingly soluble in aqueous buffers.
• Evidence suggests Myricetin's potential efficacy in managing conditions such as osteoporosis, Alzheimer's disease, cancer, diabetes, and inflammatory disorders.

Conclusions:

• Myricetin possesses significant and diverse pharmacological properties with potential therapeutic applications across a wide range of diseases.
• Further research into Myricetin's mechanisms of action and clinical efficacy is warranted.
• Its natural origin and multifaceted biological activities make Myricetin a promising candidate for drug development.